Standout Papers

Prediction of Coronary Heart Disease Using Risk Factor Categories 1990 2026 2002 2014 6.9k
  1. Prediction of Coronary Heart Disease Using Risk Factor Categories (1998)
    Peter W.F. Wilson, Ralph B. D’Agostino et al. Circulation
  2. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults (2013)
    Neil J. Stone, Jennifer G. Robinson et al. Circulation
  3. Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study (1990)
    Daniel Levy, Robert J. Garrison et al. New England Journal of Medicine
  4. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk (2013)
    David C. Goff, Donald M. Lloyd‐Jones et al. Journal of the American College of Cardiology
  5. Impact of Atrial Fibrillation on the Risk of Death (1998)
    Emelia J. Benjamin, Philip A. Wolf et al. Circulation
  6. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults (2013)
    Neil J. Stone, Jennifer G. Robinson et al. Journal of the American College of Cardiology
  7. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk (2013)
    David C. Goff, Donald M. Lloyd‐Jones et al. Circulation
  8. Obesity and the Risk of Heart Failure (2002)
    Satish Kenchaiah, Jane C. Evans et al. New England Journal of Medicine
  9. Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises (2003)
    Edward G. Lakatta, Daniel Levy Circulation
  10. Arterial Stiffness and Cardiovascular Events (2010)
    Gary F. Mitchell, Shih‐Jen Hwang et al. Circulation
  11. The epidemiology of heart failure: The Framingham Study (1993)
    Kalon K.L. Ho, Joan L. Pinsky et al. Journal of the American College of Cardiology
  12. Hemodynamic Patterns of Age-Related Changes in Blood Pressure (1997)
    Stanley S. Franklin, William Gustin et al. Circulation
  13. Long-Term Trends in the Incidence of and Survival with Heart Failure (2002)
    Daniel Levy, Satish Kenchaiah et al. New England Journal of Medicine
  14. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available. (1998)
    William B. Kannel, Philip A. Wolf et al. The American Journal of Cardiology
  15. The Progression From Hypertension to Congestive Heart Failure (1996)
    Daniel Levy JAMA
  16. Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease (2001)
    Ramachandran S. Vasan, Martin G. Larson et al. New England Journal of Medicine
  17. Lifetime Risk for Development of Atrial Fibrillation (2004)
    Donald M. Lloyd‐Jones, Thomas J. Wang et al. Circulation
  18. Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality (2003)
    Thomas J. Wang, Martin G. Larson et al. Circulation
  19. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. (1993)
    Kalon K.L. Ho, Karen M. Anderson et al. Circulation
  20. Impact of Reduced Heart Rate Variability on Risk for Cardiac Events (1996)
    Hisako Tsuji, Martin G. Larson et al. Circulation
  21. Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease? (1999)
    Stanley S. Franklin, Shehzad Akbar Khan et al. Circulation
  22. Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women (2004)
    Gary F. Mitchell, Helen Parise et al. Hypertension
  23. Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death (2004)
    Thomas J. Wang, Martin G. Larson et al. New England Journal of Medicine
  24. Lifetime Risk for Developing Congestive Heart Failure (2002)
    Donald M. Lloyd‐Jones, Martin G. Larson et al. Circulation
  25. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study (2015)
    Renate B. Schnabel, Xiaoyan Yin et al. The Lancet
  26. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction (1999)
    Ramachandran S. Vasan, Martin G. Larson et al. Journal of the American College of Cardiology
  27. Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study (1999)
    Bruce F. Culleton, Martin G. Larson et al. Annals of Internal Medicine
  28. Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death (2006)
    Thomas J. Wang, Philimon Gona et al. New England Journal of Medicine
  29. Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging? (2001)
    Stanley S. Franklin, Martin G. Larson et al. Circulation
  30. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (2013)
    Syed Mahmood, Daniel Levy et al. The Lancet
  31. Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men (2002)
    Ramachandran S. Vasan, Alexa Beiser et al. JAMA
  32. Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age (2006)
    Donald M. Lloyd‐Jones, Eric Leip et al. Circulation
  33. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) (1999)
    Jagmeet Singh, Jane C. Evans et al. The American Journal of Cardiology
  34. Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises (2003)
    Edward G. Lakatta, Daniel Levy Circulation
  35. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. (1994)
    Martin G. Larson, Emelia J. Benjamin et al. Circulation
  36. Left Atrial Size and the Risk of Stroke and Death (1995)
    Emelia J. Benjamin, Ralph B. D’Agostino et al. Circulation
  37. Incidence and Prognosis of Syncope (2002)
    Elpidoforos S. Soteriades, Jane C. Evans et al. New England Journal of Medicine
  38. Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension (2012)
    Bernhard M. Kaess, Jian Rong et al. JAMA
  39. Impact of Obesity on Plasma Natriuretic Peptide Levels (2004)
    Thomas J. Wang, Martin G. Larson et al. Circulation
  40. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study (2009)
    Renate B. Schnabel, Lisa Sullivan et al. The Lancet
  41. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study (2001)
    Ramachandran S. Vasan, Martin G. Larson et al. The Lancet
  42. Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study (1987)
    Daniel Levy, Daniel D. Savage et al. The American Journal of Cardiology
  43. Prevalence and Clinical Outcome of Mitral-Valve Prolapse (1999)
    Lisa A. Freed, Daniel Levy et al. New England Journal of Medicine
  44. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective (1995)
    Ramachandran S. Vasan, Emelia J. Benjamin et al. Journal of the American College of Cardiology
  45. Echocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors (1988)
    Daniel Levy et al. Annals of Internal Medicine
  46. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency (1999)
    Bruce F. Culleton, Martin G. Larson et al. Kidney International
  47. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death (1998)
    Agha W. Haider, Martin G. Larson et al. Journal of the American College of Cardiology
  48. Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction (2003)
    Ramachandran S. Vasan, Lisa Sullivan et al. Circulation
  49. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: Design, Recruitment, and Initial Examination (2007)
    Greta Lee Splansky, David P. Corey et al. American Journal of Epidemiology
  50. Risk factors for incident radiographic knee osteoarthritis in the elderly. The framingham study (1997)
    David T. Felson, Yuqing Zhang et al. Arthritis & Rheumatism
  51. A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community (2003)
    Thomas J. Wang, Joseph M. Massaro et al. JAMA
  52. Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly Cohort (1989)
    Daniel Levy et al. Annals of Internal Medicine
  53. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) (1992)
    Alex Sagie, Martin G. Larson et al. The American Journal of Cardiology
  54. Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals (2005)
    Johan Ärnlöv, Jane C. Evans et al. Circulation
  55. The incidence and natural history of knee osteoarthritis in the elderly, the framingham osteoarthritis study (1995)
    David T. Felson, Yuqing Zhang et al. Arthritis & Rheumatism
  56. Atrial Fibrillation Begets Heart Failure and Vice Versa (2016)
    Rajalakshmi Santhanakrishnan, Na Wang et al. Circulation
  57. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study (2008)
    Abbas Dehghan, Anna Köttgen et al. The Lancet
  58. Rare independent mutations in renal salt handling genes contribute to blood pressure variation (2008)
    Weizhen Ji, Jia Nee Foo et al. Nature Genetics
  59. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study (2008)
    Amir A. Mahabadi, Joseph M. Massaro et al. European Heart Journal
  60. Defining Diastolic Heart Failure (2000)
    Ramachandran S. Vasan, Daniel Levy Circulation
  61. Circadian variation in the incidence of sudden cardiac death in the framingham heart study population (1987)
    Stefan N. Willich, Daniel Levy et al. The American Journal of Cardiology
  62. Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction (2009)
    Douglas S. Lee, Philimon Gona et al. Circulation
  63. Prognostic Utility of Novel Biomarkers of Cardiovascular Stress (2012)
    Thomas J. Wang, Kai C. Wollert et al. Circulation

Immediate Impact

3 by Nobel laureates 22 from Science/Nature 124 standout
Sub-graph 1 of 18

Citing Papers

The changing landscape of atherosclerosis
2021 StandoutNature
A brief history of human disease genetics
2020 StandoutNature
28 intermediate papers

Works of Daniel Levy being referenced

70-year legacy of the Framingham Heart Study
2019
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
2013 Standout
and 17 more

Author Peers

Author Last Decade Papers Cites
Daniel Levy 88384 13178 6051 24628 18947 807 138.9k
William B. Kannel 69673 8969 4688 22477 25140 475 125.2k
Salim Yusuf 104588 8057 2861 28566 23902 1.3k 156.2k
Ramachandran S. Vasan 55741 12518 4239 13453 15602 941 105.1k
Peter W.F. Wilson 34252 10750 7474 30320 29024 632 107.0k
John J.V. McMurray 84097 12924 1590 22055 29299 1.5k 126.4k
Emelia J. Benjamin 68687 7120 2732 11568 8206 766 98.8k
Martin G. Larson 51911 9801 3835 12342 9351 580 86.7k
Stuart Pocock 34883 7378 2862 31770 15196 569 137.2k
Deepak L. Bhatt 55509 9122 1412 38853 22590 2.0k 103.4k
Gregg C. Fonarow 76391 5730 611 17156 9723 1.8k 109.2k

All Works

Loading papers...

Rankless by CCL
2026